Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs
Alfredo Carrato, Alfredo Falcone, Michel Ducreux, et al.
Journal of Gastrointestinal Cancer (2015) Vol. 46, Iss. 3, pp. 201-211
Open Access | Times Cited: 237

Showing 26-50 of 237 citing articles:

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial
Tanios Bekaii‐Saab, Takuji Okusaka, David Goldstein, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101897-101897
Open Access | Times Cited: 18
Application of three-dimensional (3D) bioprinting in anti-cancer therapy
Bingxuan Wu, Zheng Wu, Yan-Yu Hou, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20475-e20475
Open Access | Times Cited: 18
Predictive global trends in the incidence and mortality of pancreatic cancer based on geographic location, socio‐economic status, and demographic shift
Chandrakanth Are, Sanjib Chowdhury, Humera F. Ahmad, et al.
Journal of Surgical Oncology (2016) Vol. 114, Iss. 6, pp. 736-742
Closed Access | Times Cited: 59
Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma
Susanna Hegewisch‐Becker, Ali Aldaoud, Thomas Wolf, et al.
International Journal of Cancer (2018) Vol. 144, Iss. 5, pp. 981-990
Open Access | Times Cited: 57
Timing of palliative care referral and aggressive cancer care toward the end-of-life in pancreatic cancer: a retrospective, single-center observational study
Natasha Michael, Greta Beale, Clare O’Callaghan, et al.
BMC Palliative Care (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 51
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC)
L. Bengt van Rijssen, Arja Gerritsen, Inge Henselmans, et al.
Annals of Surgery (2017) Vol. 270, Iss. 1, pp. 158-164
Closed Access | Times Cited: 50
Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center
Gabriel Carvajal, Denis Dupoiron, Valérie Seegers, et al.
Anesthesia & Analgesia (2018) Vol. 126, Iss. 6, pp. 2038-2046
Open Access | Times Cited: 48
Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods
Roshanak Shams, Samaneh Saberi, Mohammad Reza Zali, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 48
Postoperative surveillance of pancreatic cancer patients
Lois A. Daamen, Vincent P. Groot, Martijn Intven, et al.
European Journal of Surgical Oncology (2019) Vol. 45, Iss. 10, pp. 1770-1777
Closed Access | Times Cited: 44
microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells
Maria Mortoglou, Francesc Miralles, Elif Damla Arısan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1275-1275
Open Access | Times Cited: 25
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
Maria Victoria García‐Ortiz, Pablo Cano-Ramírez, Marta Toledano‐Fonseca, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Mistletoe extract in patients with advanced pancreatic cancer: a double-blind, randomized, placebo-controlled trial (MISTRAL)
Kathrin Wode, Gunver S. Kienle, Ove Björ, et al.
Deutsches Ärzteblatt international (2024)
Open Access | Times Cited: 5
Familial Pancreatic Cancer
Julia Benzel, Volker Fendrich
Oncology Research and Treatment (2018) Vol. 41, Iss. 10, pp. 611-618
Open Access | Times Cited: 46
Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin
Richard Hubner, Antonio Cubillo, Jean–Frédéric Blanc, et al.
European Journal of Cancer (2018) Vol. 106, pp. 24-33
Open Access | Times Cited: 45
Metabolomics in pancreatic cancer biomarkers research
Jaroslav Tumas, Kotryna Kvederavičiūtė, Marius Petrulionis, et al.
Medical Oncology (2016) Vol. 33, Iss. 12
Closed Access | Times Cited: 44
Clinical Effectiveness and Potential Survival Benefit of US-Guided High-Intensity Focused Ultrasound Therapy in Patients with Advanced-Stage Pancreatic Cancer
Milka Marinova, Hannah C. Huxold, J. Henseler, et al.
Ultraschall in der Medizin - European Journal of Ultrasound (2018) Vol. 40, Iss. 05, pp. 625-637
Closed Access | Times Cited: 44
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib
P. Hammel, Hedy L. Kindler, Michele Reni, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1959-1968
Open Access | Times Cited: 41
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study
Yung‐Jue Bang, Chung‐Pin Li, Kyung‐Hun Lee, et al.
Cancer Science (2019) Vol. 111, Iss. 2, pp. 513-527
Open Access | Times Cited: 37
Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward
Caspar Franck, Christian D. Muller, Rosa Rosania, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1955-1955
Open Access | Times Cited: 35
Improving quality of life in pancreatic cancer patients following high-intensity focused ultrasound (HIFU) in two European centers
Milka Marinova, Hyuliya Feradova, Maria A. Gonzalez‐Carmona, et al.
European Radiology (2021) Vol. 31, Iss. 8, pp. 5818-5829
Closed Access | Times Cited: 28
Natural Language Processing for Automated Classification of Qualitative Data From Interviews of Patients With Cancer
Chao Fang, Natasha Markuzon, Nikunj Patel, et al.
Value in Health (2022) Vol. 25, Iss. 12, pp. 1995-2002
Open Access | Times Cited: 22
Quality of Life in Patients with Pancreatic Cancer—A Literature Review
Elżbieta Cipora, Aleksandra Czerw, Olga Partyka, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 6, pp. 4895-4895
Open Access | Times Cited: 12
Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
Maria Victoria García‐Ortiz, Pablo Cano-Ramírez, Marta Toledano‐Fonseca, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Treatment Costs and Social Burden of Pancreatic Cancer
Elżbieta Cipora, Olga Partyka, Monika Pajewska, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1911-1911
Open Access | Times Cited: 11
Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in Spain
Rafael Álvarez-Gallego, Roberto Pazo-Cid, Borja Lopez De San Vicente, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access

Scroll to top